Nontuberculous mycobacterial lung diseases

Infectious Disease Clinics of North America

Volumn 24, Issue 3, 2010, Pages 769-789

  Taiwo, Babafemi ^a   Glassroth, Jeff ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Lung disease; Macrolides; Mycobacterium tuberculosis; Nontuberculous mycobacteria

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; AZITHROMYCIN; CEFOXITIN; CLARITHROMYCIN; CORTICOSTEROID; CYTOKINE; DOXYCYCLINE; ETHAMBUTOL; GAMMA INTERFERON; IMIPENEM; INFLIXIMAB; INTERLEUKIN 12; ISONIAZID; LINEZOLID; MACROLIDE; MINOCYCLINE; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; STREPTOMYCIN; SULFAMETHOXAZOLE; TOBRAMYCIN; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ATYPICAL MYCOBACTERIOSIS; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BRONCHIECTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DERMATOMYOSITIS; DIAGNOSTIC TEST; DRESS SYNDROME; DRUG DOSE ESCALATION; DRUG INTERMITTENT THERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INCIDENCE; INFECTION SENSITIVITY; LABORATORY TEST; LUNG CAVITATION; LUNG INFECTION; LUNG SURGERY; MICROBIOLOGICAL EXAMINATION; MIXED INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM XENOPEI; NONHUMAN; PATHOGENESIS; POLYMYOSITIS; PREVALENCE; REVIEW; SPUTUM SMEAR; CLASSIFICATION; ISOLATION AND PURIFICATION; LUNG DISEASES; MICROBIOLOGY; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; PATHOGENICITY; PATHOLOGY;

ANTI-BACTERIAL AGENTS; HUMANS; LUNG DISEASES; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS;

EID: 77955245664     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2010.04.008     Document Type: Review

References (92)

1. Glassroth J. Pulmonary disease due to nontuberculous mycobacteria. Chest 2008, 133:243-251.
2. Ostroff S, Hutwagner L, Collin S. Mycobacterial species and drug resistance patterns reported by state laboratories-1992. 93rd American Society for Microbiology. General Meeting, May 16, 1993, Atlanta (GA); abstract U-9:170.
3. Good R.C., Snider D.E. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982, 146:829-833.
4. Marras T.K., Chedore P., Ying A.M., et al. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997-2003. Thorax 2007, 62:661-666.
5. Falkinham J.O. Nontuberculous mycobacteria in the environment. Clin Chest med 2002, 23(3):529-551.
6. Taylor R.H., Falkinham J.O., Norton C.D., et al. Chlorine, chloramine, chlorine dioxide, and ozone susceptibility of Mycobacterium avium. Appl Environ Microbiol 2000, 66:1702-1705.
7. Hilborn E.D., Covert T.C., Yakrus M.A., et al. Persistence of nontuberculous mycobacteria in a drinking water system after addition of filtration treatment. Appl Environ Microbiol 2006, 72(9):5864-5869.
8. Schulze-Robbecke R., Buchholtz K. Heat susceptibility of aquatic mycobacteria. Appl Environ Microbiol 1992, 58(6):1869-1873.
9. Khoor A., Leslie K.O., Tazelaar H.D., et al. Diffuse pulmonary disease caused by nontuberculous mycobacteria in immune competent people (hot tub lung). Am J Clin Pathol 2001, 115:755-762.
10. Centers for Disease Control and Prevention (CDC) Respiratory illness in workers exposed to metal working fluid contaminated with nontuberculous mycobacteria. Ohio, 2001. MMWR Morb Wkly Rep 2002, 51(16):349-352.
11. Bodle E.E., Cunningham J.A., Della-Latta P., et al. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008, 14(3):390-396.
12. Koh W.J., Kwon O.J., Jeon K., et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006, 129:341-348.
13. Corbett E.L., Hay M., Churchyard G.J., et al. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology. Int J Tuberc Lung Dis 1999, 3(6):501-507.
14. Han X.Y., Tarrand J.J., Infante R., et al. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 2005, 43(9):4407-4412.
15. Tateishi Y., Hirayama Y., Ozeki Y., et al. Virulence of Mycobacterium avium complex strains isolated from immunocompetent patients. Microb Pathol 2009, 46(1):6-12.
16. Schorey J.S., Carroll M.C., Brown E.J. A macrophage invasion mechanism for pathogenic mycobacteria. Science 1997, 277:1091-1093.
17. Esteban J., Martin-de-Hijas N., Kinnari T.J., et al. Biofilm development by potentially pathogenic non-pigmented rapidly growing bacteria. BMC Microbiol 2008, 8:184.
18. Sexton P., Harrison A.C. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 2008, 31:1322-1333.
19. Vankayalapati R., Wizel B., Samten B., et al. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis 2001, 183(3):478-484.
20. Dorman S.E., Holland S.M. Interferon-gamma and interleukin-12 pathway defects in human disease. Cytokine Growth Factor Rev 2000, 11:321-333.
21. Kim R.D., Greenberg D.E., Ehrmantraut M.E., et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 2008, 178:1066-1074.
22. Greinert U., Schlaak M., Rusch-Gerdes S., et al. Low in vitro production of interferon gamma and tumor necrosis factor-alpha in HIV seronegative patients with pulmonary disease caused by nontuberculous bacteria. J Clin Immunol 2000, 20:445-452.
23. Safdar A., White D.A., Stover D., et al. Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculosis mycobacteriosis. Am J Med 2002, 113:756-759.
24. Kwon Y.S., Kim E.J., Lee S., et al. Decreased cytokine production in patients with nontuberculous mycobacterial lung disease. Lung 2007, 185:337-341.
25. Middleton A.M., Chadwick M.V., Nicholson A.G., et al. Inhibition of adherence of Mycobacterium avium complex and Mycobacterium tuberculosis to fibronectin on the respiratory mucosa. Respir Med 2004, 98:1203-1206.
26. Middleton A.M., Chadwick M.V., Nicholson A.G., et al. The role of Mycobacterium avium complex fibronectin attachment protein in adherence to the human respiratory mucosa. Mol Microbiol 2000, 38:381-391.
27. Huang J.H., Kao P.N., Adi V., et al. Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 1999, 115(4):1033-1040.
28. Iseman M.D., Buschman D.L., Ackerson L.M. Pectus excavatum and scoliosis: thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991, 144:914-916.
29. Kalayjian R.C., Toossi Z., Tomashefski J.F., et al. Pulmonary disease due to infection by Mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1995, 20(5):1186-1194.
30. Doucette K., Fishman J.A. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004, 38(10):1428-1439.
31. Salvana E.M., Cooper G.S., Salata R.A. Mycobacterium other than tuberculosis (MOTT) infection: an emerging disease in infliximab-treated patients. J Infect 2007, 55(6):484-487.
32. Tanaka G., Shojima J., Matsushita I., et al. Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphism. Eur Respir J 2007, 30:90-96.
33. Dailloux M., Abalain M.L., Laurain C., et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006, 28(6):1211-1215.
34. Kobashi Y., Fukuda M., Yoshida K., et al. Four cases of pulmonary Mycobacterium avium intracellulare complex presenting as a solitary pulmonary nodule and a review of the other cases in Japan. Respirology 2006, 11:317-321.
35. Woodring J.H., Vandiviere H.M., Melvin I.G., et al. Roentgenographic features of pulmonary disease caused by atypical mycobacteria. South Med J 1987, 80(12):1488-1497.
36. Reich J.M., Johnson R.E. Mycobacterium avium complex pulmonary disease. Incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 1991, 143:1381-1385.
37. Christensen E.E., Dietz G.W., Ahn C.H., et al. Initial roetgenographic manifestations of pulmonary Mycobacterium tuberculosis. M kansasii and M intracellularis infections. Chest 1981, 80(2):132-136.
38. Albelda S.M., Kern J.A., Marinelli D.L., et al. Expanding spectrum of pulmonary disease caused by nontuberculous mycobacteria. Radiology 1985, 157:289-296.
39. Reich J.M., Johnson R.E. Mycobacterium avium complex pulmonary disease presenting as an isolated lingula or middle lobe pattern. The Lady Windermere syndrome. Chest 1992, 101(6):1605-1609.
40. Bradham R.R., Sealy W.C., Young W.G., et al. Chronic middle lobe infection. Factors responsible for its development. Ann Thorac Surg 1966, 2:612-616.
41. Wallace R.J., Zhang Y., Brown B.A., et al. Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis. Am J Respir Crit Care Med 1998, 158(4):1235-1244.
42. Tanaka E., Amitani R., Niimi A., et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997, 155(6):2041-2046.
43. Marras T.K., Wallace R.J., Koth L.L., et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005, 127:664-671.
44. Embil J., Warren P., Yakrus M., et al. Pulmonary illness associated with exposure to Mycobacterium avium complex in hot tub water. Hypersensitivity pneumonitis or infection?. Chest 1997, 111:813-816.
45. Marchetti N., Criner K., Criner G.J. Characterization of functional, radiologic and lung function recovery post treatment of hot tub lung. A case report and review of the literature. Lung 2004, 182:271-277.
46. Agarwal R., Nath A. Hot-tub lung: hypersensitivity to Mycobacterium avium but not hypersensitivity pneumonitis. Respir Med 2006, 100(8):1478.
47. Pham R.V., Vydareny K.H., Gal A.A. High-resolution computed tomography appearance of pulmonary Mycobacterium avium complex infection after exposure to hot tub: case of hot-tub lung. J Thorac Imaging 2003, 18:48-52.
48. Benson C.A., Ellner J.J. Mycobacterium avium complex and AIDS: advances in theory and practice. Clin Infect Dis 1993, 17:7-20.
49. Salama C., Policar M., Venkataraman M. Isolated pulmonary Mycobacterium avium complex infection in patients with human immunodeficiency virus infection: case reports and literature review. Clin Infect Dis 2003, 37:e35-e40.
50. Corbett E.L., Blumberg L., Churchyard G.J., et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999, 160:15-21.
51. Kerbiriou L., Ustianowski A., Johnson M.A., et al. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat?. Clin Infect Dis 2003, 37:1250-1254.
52. Marie I., Heliot P., Roussel F., et al. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab. Rheumatology (Oxford) 2005, 44:1201-1202.
53. Pierre-Audigier C., Ferroni A., Sermet-Gaudeleus I., et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005, 3:3467-3470.
54. Mussaffi H., Rivlin J., Shalit I., et al. Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J 2005, 25:324-328.
55. Olivier K.N. NTM in CF Study Group. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr Respir Rev 2004, 5(SUPPL A):S213-S216.
56. Griffith D.E., Aksamit T., Brown-Elliott B.A., et al. on behalf of the ATS Mycobacterial Diseases Subcommittee. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175:367-416.
57. Chalermskulrat W., Sood N., Neuringer P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax 2006, 61:507-513.
58. Taillard C., Greub G., Weber R., et al. Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey. J Clin Microbiol 2003, 41(3):1240-1244.
59. Lillo M., Orengo S., Cernoch P., et al. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990, 12(5):760-767.
60. Griffith D.E., Girard W.M., Wallace R.J. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993, 147:1271.
61. Cullen A.R., Cannon C.L., Mark E.J., et al. Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?. Am J Respir Crit Care Med 2000, 161(2 Pt 1):641-645.
62. Ohno H., Matsuo N., Suyama N., et al. The first surgical case of pulmonary Mycobacterium malmoense infection in Japan. Intern Med 2008, 47(24):2187-2190.
63. Henriques B., Hoffner S.E., Petrini B., et al. Infection with Mycobacterium malmoense in Sweden: report of 221 cases. Clin Infect Dis 1994, 18(4):596-600.
64. Buchholz U.T., McNeil M.M., Keyes L.E., et al. Mycobacterium malmoense infections in the United States, January 1993 through June 1995. Clin Infect Dis 1998, 27(3):551-558.
65. Evans A.J., Crisp A.J., Colville A., et al. Pulmonary infections caused by Mycobacterium malmoense and Mycobacterium tuberculosis: comparison of radiographic features. AJR Am J Roentgenol 1993, 161:733-737.
66. Murasic A., Katalinic-Jankovic V., Popovic-Grie S., et al. Mycobacterium xenopi pulmonary disease-epidemiology and clinical features in non-immunocompromised patients. J Infect 2009, 589:108-112.
67. Jiva T.M., Jacoby H.M., Weymouth L.A., et al. Mycobacterium xenopi: innocent bystander or emerging pathogen?. Clin Infect Dis 1997, 24:226-232.
68. Tortoli E., Besozzi G., Lacchini C., et al. Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature. Eur Respir J 1998, 11:975-977.
69. Ergan B., Coplu L., Alp A., et al. Mycobacterium smegmatis pneumonia. Respirology 2004, 9:283-285.
70. Fujita J., Ohtsuki Y., Suemitsu I., et al. Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex pulmonary disease. Eur Respir J 1999, 13:535-540.
71. Rossman M.D. Colonization with Mycobacterium avium complex-an outdated concept. Eur Respir J 1999, 13(3):479.
72. Olivier K.N., Yankaskas J.R., Knowles M.R., et al. Non-tuberculous mycobacterial pulmonary disease in cystic fibrosis. Semin Respir Infect 1996, 11:272-284.
73. Kuroishi S., Nakamura Y., Hayakawa H., et al. Mycobacterium avium complex disease: prognostic implications of high-resolution computed tomography findings. Eur Respir J 2008, 32(1):147-152.
74. Somoskovi A., Hotaling J.E., Fitzgerald M., et al. Lessons from a proficiency testing event for acid-fast microscopy. Chest 2001, 120(1):250-257.
75. Neonakis I.K., Gitti Z., Krambovitis E., et al. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods 2008, 75:1-11.
76. Daley P., Petrich A., May K., et al. Comparison of in-house and commercial 16S rRNA sequencing with high-performance liquid chromatography and genotype AS and CM for identification of nontuberculous mycobacteria. Diagn Mcrobiol Infect Dis 2008, 61(3):284-293.
77. Lam P.K., Griffith D.E., Aksamit T.R. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006, 173:1283-1289.
78. Wallace R.J., Brown B.A., Griffith D.E., et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. Am J Respir Crit Care Med 1994, 149(5):1335-1341.
79. Kobashi Y., Yoshida K., Miyashita N., et al. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother 2006, 12:195-202.
80. Kobashi Y., Matsushima T., Ok M. A double blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007, 101:130-138.
81. Wallace R.J., Zhang Y., Brown-Elliott B.A., et al. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. J Infect Dis 2002, 186(2):266-273.
82. Griffith D.E., Brown-Elliott B.A., Langsjoen B., et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006, 174:928-934.
83. Griffith D.E., Brown-Elliott B.A., Wallace R.J. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003, 37(9):1178-1182.
84. Sauret J., Hernandez-Flix S., Castro E., et al. Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis 1995, 76(2):104-108.
85. Santin M., Dorca J., Alcaide F., et al. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease. Eur Respir J 2009, 33:148-152.
86. Alcaide F., Calatayud L., Santin M., et al. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin and four conventional antimycobacterial drugs against Mycobacterium kansasii. Antimicrobial Agents Chemother 2004, 48(12):4562-4565.
87. Daley C.L., Griffith D.E. Pulmonary disease caused by rapidly growing mycobacteria. Clin Chest Med 2002, 23(3):623-632.
88. Rodriguez Diaz J.C., Lopez M., Ruiz M., et al. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria. Int J Antimicrob Agents 2003, 21(6):585-588.
89. Jeon K., Kwon O.J., Lee N.Y., et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care med 2009, 180(9):896-902.
90. Jenkins P.A., Campbell I.A., Research Committee of The British Thoracic Society Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five-year follow-up of patients receiving standardized treatment. Respir Med 2003, 97:439-444.
91. Andrejak C., Lescure F.X., Douadi, et al. Non-tuberculous mycobacteria pulmonary infection: management and follow-up of 31 infected patients. J Infect 2007, 55(1):34-40.
92. Shiraishi Y., Nakajima Y., Katsuragi N., et al. Pneumonectomy for nontuberculous mycobacterial infections. Ann Thorac Surg 2004, 78:399-403.